Abstract
Evidence has linked head trauma to increased risk factors for neuropathology, including mechanical deformation of the sulcal fundus and, later, perivascular accumulation of hyperphosphorylated tau adjacent to these spaces related to chronic traumatic encephalopathy (CTE). However, little is known about microstructural abnormalities and cellular dyshomeostasis at the acute stage of mild traumatic brain injury (mTBI) in humans, particularly in the cortex. To address this gap, we designed the first architectonically motivated quantitative susceptibility mapping (QSM) study to assess regional patterns of positive (iron-related) and negative (myelin-, calcium-, and protein-related) magnetic susceptibility across 34 cortical regions of interest following mTBI. Bilateral, between-group analyses sensitive to cortical depth and curvature were conducted between 25 males with acute (< 14 days) sports-related mTBI (sr-mTBI) and 25 age-matched male controls. Results suggest a trauma-induced increase in positive susceptibility focal to superficial, perivascular-adjacent spaces in the parahippocampal sulcus. Co-localised decreases in diamagnetism indicate a dual pathology of neural substrates. These mTBI-related patterns were distinct from age-related processes, as revealed by correlation analyses. Our findings suggest depth- and curvature-specific deposition of biological substrates in cortical tissue following mTBI, and the coherence between the superficial sulcal predilection and pathognomonic patterns of misfolded proteins in trauma-related neurodegeneration is interesting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a grant from the Health Research Council of New Zealand (HRC), grant #21/622.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Auckland University of Technology Ethics Committee gave ethical approval for this work The Health and Disabilities Ethics Committee gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Reformatted for readability and per APA standards Shortened abstract for readability
